FIELD: bioinformatics.
SUBSTANCE: disclosed is a method for inferring the conclusion on the activity of the cell signaling pathway based on the expression levels of at least three target genes.
EFFECT: present invention can be used in diagnosing various diseases.
13 cl, 25 dwg, 11 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ASSESSING ACTIVITY OF CELL SIGNALING PATHWAYS USING PROBABILISTIC MODELING OF EXPRESSION OF TARGET GENES | 2012 |
|
RU2719194C2 |
| DELIVERY, USE AND USE IN THERAPY OF CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETED ACTION ON DISORDERS AND DISEASES USING VIRAL COMPONENTS | 2014 |
|
RU2716421C2 |
| COMPOSITIONS AND METHODS FOR IMMUNE ONCOLOGY | 2016 |
|
RU2771624C2 |
| HSD17B13 OPTIONS AND THEIR APPLICATIONS | 2018 |
|
RU2760851C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED ACTION AND MODELING OF DISEASES AND DISORDERS OF POSTMITOTIC CELLS | 2014 |
|
RU2725502C2 |
| DNA-CONTAINING POLYNUCLEOTIDES AND GUIDE SEQUENCES FOR CRISPR TYPE V SYSTEMS AND METHODS FOR PRODUCTION AND USE THEREOF | 2021 |
|
RU2832314C1 |
| METHOD FOR INCREASING THE EXPRESSION OF ENCODED RNA PROTEINS | 2014 |
|
RU2733424C2 |
| RNA-GUIDED HUMAN GENOME ENGINEERING | 2013 |
|
RU2766685C2 |
| THERAPY METHODS BASED ON CAR T-CELLS WITH INCREASED EFFICIENCY | 2016 |
|
RU2788131C2 |
| NEW ANTIBODIES AND NUCLEOTIDE SEQUENCES AND THEIR USE | 2019 |
|
RU2802450C2 |
